News

pSivida’s Iluvien is an injectable, non-erodable, intravitreal implant for the treatment of DME, a potentially blinding condition that affects approximately one million people in the US. Iluvien is

EyeGate claimed that it is the first company to conduct multiple controlled clinical trials to assess the safety and efficacy of iontophoresis technology to deliver therapeutics into the

Richard Clark, currently chairman, president and CEO, is expected to continue leading the company as chairman and CEO. Kenneth Frazier, currently president of the Global Human Health worldwide

The SFDA has identified deception and avoidance of regulatory inspection at Jiangsu Yanshen during the second half of 2008 in the production of certain batches of human use

Alvogen said that the CRO will specialise in the management of clinical trials and offer a complete range of clinical research services to Alvogen and third parties. The

Watson’s ANDA is for a generic equivalent of Wyeth’s Rapamune tablets product. The suit was filed on 28 April, 2010 in the US District Court for the District

The AlloMap procedure was designed to analyze the expression of certain genetic markers in a transplant patient’s bloodstream and, with the help of other screening by physicians, identify

The new corporate headquarters, which is slated for completion in the spring of 2012, will be two six-story buildings totaling 425,000sqft and will cost approximately $150m. Astellas Pharma

ChronTech Pharma said that at follow-up of the ChronVac-C -study where patients now have started treatment according to standard-of-care (interferon and ribavirin) all patients (100%) were virus free